Answers are grounded in this paper and cite their sources.
A mitochondrion-targeting and photoactivatable cisplatin-based PtIV prodrug was designed to overcome drug resistance.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: